Status:
COMPLETED
Use of Local Intraoperative Steroid in MIS TLIF
Lead Sponsor:
Rush University Medical Center
Conditions:
Dysphasia
Eligibility:
All Genders
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine if the frequency and duration of postoperative pain are improved in participants receiving a local steroid injection (methylprednisolone) plus a systemic (int...
Detailed Description
Postoperative pain is a well-known complication following minimally invasive transforaminal lumbar interbody fusion (MIS TLIF). It has been found that up to 40% of lumbar spinal patients will have eit...
Eligibility Criteria
Inclusion
- Patients undergoing a primary 1- to 2-level MIS TLIF
- Diagnosis: myelopathy, radiculopathy, myeloradiculopathy, stenosis, herniated nucleus pulposus, degenerative disc disease, spondylosis, osteophytic complexes, and foraminal stenosis
- Patients able to provide informed consent
Exclusion
- Allergies or other contraindications to medicines in the protocol including:
- (a) Existing history of gastrointestinal bleeding
- Current Smokers
- Lumbar spine trauma
- Bilateral cages
- Lack of consent
Key Trial Info
Start Date :
November 13 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 3 2019
Estimated Enrollment :
105 Patients enrolled
Trial Details
Trial ID
NCT03308084
Start Date
November 13 2015
End Date
May 3 2019
Last Update
November 20 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.